The diverse functions of the PD1 inhibitory pathway | Nature Reviews Immunology
Frontiers | PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy
Current and Future Perspectives of PD-1/PDL-1 Blockade in Cancer Immunotherapy
Frontiers | Looking for the Optimal PD-1/PD-L1 Inhibitor in Cancer Treatment: A Comparison in Basic Structure, Function, and Clinical Practice
Ezabenlimab | Investigational Compounds | InOncology
Frontiers | Current Advances in PD-1/PD-L1 Blockade in Recurrent Epithelial Ovarian Cancer
Checkpoint Inhibitor Use Changed for Bladder Cancer - NCI
Small molecule inhibitors targeting the PD-1/PD-L1 signaling pathway | Acta Pharmacologica Sinica
Radiotherapy and anti-PD-1/PD-L1 combinations in lung cancer: building better translational research platforms - Annals of Oncology
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?
An Avidity-Based PD-L1 Antagonist Using Nanoparticle-Antibody Conjugates for Enhanced Immunotherapy | Nano Letters
Natural killer cells and immune-checkpoint inhibitor therapy: Current knowledge and new challenges: Molecular Therapy - Oncolytics
Development of PD-1 and PD-L1 inhibitors as a form of cancer immunotherapy: a comprehensive review of registration trials and future considerations | Journal for ImmunoTherapy of Cancer
Understanding and overcoming the resistance of cancer to PD-1/PD-L1 blockade - ScienceDirect
Definition of immune checkpoint inhibitor - NCI Dictionary of Cancer Terms - NCI
Predictive biomarkers and mechanisms underlying resistance to PD1/PD-L1 blockade cancer immunotherapy | Molecular Cancer | Full Text
Mechanism of action of PD-1 and PD-L1 inhibitors. The programmed cell... | Download Scientific Diagram
The roles of PD-1/PD-L1 in the prognosis and immunotherapy of prostate cancer: Molecular Therapy
Programmed cell death-1/programmed cell death ligand-1 checkpoint inhibitors: differences in mechanism of action | Immunotherapy
Study and analysis of antitumor resistance mechanism of PD1/PD‐L1 immune checkpoint blocker - Wang - 2020 - Cancer Medicine - Wiley Online Library
Mechanism of action of PD-1 and PD-L1 inhibitors. The programmed cell... | Download Scientific Diagram
Immune-related adverse events of checkpoint inhibitors | Nature Reviews Disease Primers
Are PD-1 and PD-L1 Checkpoint Inhibitors As Good As We Thought?
